Dynamic remodeling of the endomembrane system is a core biological process essential for maintaining cellular ...

Having that in mind, we will go over the BiS gear, talents and runes for Tank Shamans in Season of Discovery Phase 8. For the talents, you will need to spend 30 points into Elemental, and 21 in ...

HHS and FDA are planning to phase out eight synthetic food dyes. During a press conference on Tuesday, Health and Human Services Secretary Robert F. Kennedy Jr. unveiled a plan to start phasing ...

As­cle­tis Phar­ma’s obe­si­ty pill was less ef­fec­tive at its high dose than at low­er dos­es in an ear­ly-stage tri­al, the biotech ...

WASHINGTON (AP) — U.S. health officials on Tuesday said they would phase out petroleum-based artificial colors in the nation’s food supply, potentially triggering an ingredients overhaul for ...

Rabat – Morocco is stepping up efforts to strengthen and diversify its gas resources as the country aims to develop the first phase of a liquefied natural gas terminal near the eastern city of ...

GREEN BAY (NBC 26) — Phase 4 of the NFL Draft begins as early as noon Wednesday, starting on the east of the Draft campus and moving west. More overnight impacts include the Interstate 41 Exit ...

In bronchiectasis, neutrophilic inflammation is associated with an increased risk of exacerbations and disease progression. Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1 ...

WASHINGTON, Apr. 23, 2025— The World Bank Group today announced the launch of the next phase of its Private Sector Investment Lab, focused on implementing proven solutions at scale. This new chapter ...

Credit: Dennis Diatel / Shutterstock. US-based pharmaceutical company Bristol Myers Squibb (BMS) has reported topline outcomes from the Phase III ARISE trial of Cobenfy as an adjunctive treatment to ...

The Departments of Basic Education and Employment and Labour have called on all qualifying people to apply for Phase V of the Basic Education Employment Initiative through the SAYouth.mobi portal.

Vertex Pharmaceuticals is conducting the pivotal phase 3 portion of a phase 1/2/3 study of zimislecel (formerly VX-880) in those with type 1 diabetes who have had severe hypoglycemic events.